Comments
Loading...
Ultragenyx Pharmaceutical (RARE) Forecast
NewsEarningsUltragenyx Pharmaceutical (RARE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestUltragenyx Pharmaceutical (NASDAQ:RARE) Stock Quotes, Forecast and News Summary
Ultragenyx Pharmaceutical Stock (NASDAQ: RARE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Ultragenyx Pharmaceutical (RARE) stock?
You can purchase shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) through any online brokerage.
Who are Ultragenyx Pharmaceutical (RARE) competitors?
Other companies in Ultragenyx Pharmaceutical’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ascentage Pharma Group (NASDAQ:AAPG), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).
What is the forecast, or price target, for Ultragenyx Pharmaceutical (RARE) stock?
Ultragenyx Pharmaceutical has a consensus price target of $93.65.
What is the current price for Ultragenyx Pharmaceutical (RARE)?
The stock price for Ultragenyx Pharmaceutical (NASDAQ: RARE) is $43.715 last updated February 21, 2025 at 10:34 AM EST.
Does Ultragenyx Pharmaceutical (RARE) pay a dividend?
There are no upcoming dividends for Ultragenyx Pharmaceutical.
When is Ultragenyx Pharmaceutical (NASDAQ:RARE) reporting earnings?
Ultragenyx Pharmaceutical’s Q1 earnings are confirmed for Thursday, May 1, 2025.
Is Ultragenyx Pharmaceutical (RARE) going to split?
There is no upcoming split for Ultragenyx Pharmaceutical.
What sector and industry does Ultragenyx Pharmaceutical (RARE) operate in?
Ultragenyx Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.